Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) is now available.
Dishman Carbogen Amcis Limited has announced the allotment of 5,000 rated, listed, senior, secured, redeemable, taxable non-convertible debentures, each with a face value of INR 1,00,000, totaling INR 50 crore. This strategic financial move, approved by the company’s board, is aimed at raising capital through private placement, potentially enhancing the company’s financial stability and market positioning.
More about Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company serves a global market, providing services and products to pharmaceutical companies.
YTD Price Performance: -20.86%
Average Trading Volume: 37,773
Current Market Cap: 35.48B INR
See more insights into DCAL stock on TipRanks’ Stock Analysis page.